FIELD: medicine.
SUBSTANCE: invention refers to medicine, and concerns compositions and methods for treating severe acute respiratory syndrome (SARS). Substance of the invention includes a pharmaceutical composition for treating severe acute respiratory syndrome SARS, containing a therapeutically effective amount of recombinant TNF-α receptor or thalidomide in a pharmaceutically acceptable carrier. Also, presented is a method of treating SARS with using this composition, as well as a method of preparing the composition.
EFFECT: drug for treating SARS is developed.
43 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CHIMERIC ANTIGEN RECEPTORS WITH MUTATED CD28 COSTIMULATION DOMAINS | 2018 |
|
RU2800922C2 |
| METHOD FOR PROMOTION OF ACTIVE CONFORMATION OF GLYCOSYLATED RECOMBINANT PROTEIN, METHOD FOR PREPARING ACTIVE GLYCOSYLATED PROTEIN AND METHOD FOR PREPARING COMPOSITION OF THIS PROTEIN FOR ADMINISTRATION TO USER AND/OR PATIENT OR FOR USING BY USER AND/OR PATIENT | 2002 |
|
RU2316563C2 |
| ANTI-GITR ANTIBODIES | 2010 |
|
RU2595409C2 |
| ANTIBODIES TO PD-1 AND METHODS OF THEIR APPLICATION | 2015 |
|
RU2701797C2 |
| ANTI-GITR ANTIBODIES | 2010 |
|
RU2646139C1 |
| SYNTHETIC VERSIONS OF HYPERGLYCOLISED PROTEASE-RESISTIVE POLYPEPTIDE, ORAL COMPOSITIONS AND METHODS OF USING SUCH VERSIONS | 2005 |
|
RU2392963C2 |
| METHODS OF APPLYING OF APO-2L-RECEPTORS AGONISTS AND NK-CELLS ACTIVATORS | 2005 |
|
RU2395294C2 |
| ANTI-IL-17F ANTIBODIES AND METHODS FOR USE THEREOF | 2010 |
|
RU2605318C2 |
| METHODS AND COMPOSITIONS FOR TREATMENT OF PERSISTENT INFECTIONS | 2016 |
|
RU2746383C2 |
| LIGAND GITR AND MOLECULES AND ANTIBODIES BOUND WITH LIGAND GITR, AND VERSIONS OF THEIR APPLICATION | 2004 |
|
RU2369636C2 |
